1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Social Phobia Global Clinical Trials Review, H2, 2014

Social Phobia Global Clinical Trials Review, H2, 2014

  • July 2014
  • -
  • Global Data
  • -
  • 71 pages

Social Phobia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Social Phobia Global Clinical Trials Review, H2, 2014" provides data on the Social Phobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Social Phobia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Social Phobia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Social Phobia Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Social Phobia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Social Phobia to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Social Phobia 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Social Phobia Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
GlaxoSmithKline plc 27
Clinical Trial Overview of GlaxoSmithKline plc 27
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
Eli Lilly and Company 29
Clinical Trial Overview of Eli Lilly and Company 29
Pherin Pharmaceuticals, Inc. 30
Clinical Trial Overview of Pherin Pharmaceuticals, Inc. 30
Neurocrine Biosciences, Inc. 31
Clinical Trial Overview of Neurocrine Biosciences, Inc. 31
Mylan Inc. 32
Clinical Trial Overview of Mylan Inc. 32
Avera Pharmaceuticals, Inc. 33
Clinical Trial Overview of Avera Pharmaceuticals, Inc. 33
Apsen Farmaceutica SA 34
Clinical Trial Overview of Apsen Farmaceutica SA 34
Clinical Trial Overview of Top Institutes / Government 35
The University of New South Wales 35
Clinical Trial Overview of The University of New South Wales 35
National Institute of Mental Health 36
Clinical Trial Overview of National Institute of Mental Health 36
Umea University 37
Clinical Trial Overview of Umea University 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
Karolinska Institute 39
Clinical Trial Overview of Karolinska Institute 39
University of California, Los Angeles 40
Clinical Trial Overview of University of California, Los Angeles 40
University of South Florida 41
Clinical Trial Overview of University of South Florida 41
University of Pittsburgh 42
Clinical Trial Overview of University of Pittsburgh 42
Macquarie University 43
Clinical Trial Overview of Macquarie University 43
Hamilton Health Sciences 44
Clinical Trial Overview of Hamilton Health Sciences 44
Five Key Clinical Profiles 45
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Social Phobia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Social Phobia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Social Phobia Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Social Phobia Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 27
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 28
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 29
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pherin Pharmaceuticals, Inc., 2014* 30
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2014* 31
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2014* 32
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Avera Pharmaceuticals, Inc., 2014* 33
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2014* 34
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014* 35
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 36
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014* 37
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 38
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 39
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 40
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 41
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 42
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2014* 43
Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 44

List of Figures
Social Phobia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Social Phobia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Social Phobia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.